N S Chandrashekar
Overview
Explore the profile of N S Chandrashekar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
26
Followers
0
Related Specialties
Related Specialties
Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chandrashekar N, Shobha Rani R
Indian J Pharm Sci
. 2010 Apr;
70(1):94-6.
PMID: 20390089
Skin of an average adult body covers a surface of approximately 2 m2 and receives about one-third of the blood circulating through the body. The transdermal route of administration cannot...
2.
Chandrashekar N, Prasanth V
Asian Pac J Cancer Prev
. 2008 Nov;
9(3):437-40.
PMID: 18990017
The aim of the present study was formulate and clinically evaluate 5-fluorouracil (5-FU) transdermal patches. Cytotoxicity was measured by exposing cell suspensions to increasing concentrations of drug from 10-100 microg/ml...
3.
Chandrashekar N, Shobha Rani R
J Mater Sci Mater Med
. 2008 Jul;
20 Suppl 1:S189-94.
PMID: 18592348
Microprocessor controlled transdermal delivery of anticancer drugs 5-Fluorouracil (5-FU) and 6-Mercaptopurine (6-MP) was developed and in vitro evaluation was done. Drugs were loaded based on the pharmacokinetics parameters. In vitro...
4.
Chandrashekar N, Hiremath S
Biol Pharm Bull
. 2008 Apr;
31(4):656-61.
PMID: 18379058
Using skin as a port for systemic drug administration, transdermal drug delivery has expanded greatly over the last two decades. Our aim was to formulate the single layer drug-in-adhesive transdermal...
5.
Chandrashekar N, Hiremath S
Recent Pat Anticancer Drug Discov
. 2008 Jan;
2(3):235-9.
PMID: 18221066
The purpose of this study was to determine the permeation of the hydrophilic compound 5-fluorouracil through human epidermal membranes, Ehrlich Ascites Carcinoma (EAC) cells were used as a model cell...
6.
Chandrashekar N, Shobha Rani R
J BUON
. 2007 Dec;
12(4):529-34.
PMID: 18067212
Purpose: The purpose of this study was to fabricate monolithic 5-fluorouracil (5-FU) transdermal patch with microprocessor- controlled iontophoretic delivery, to evaluate the pharmacodynamic effects on Dalton's lymphoma ascites (DLA) induced...